High Cholesterol News and Research RSS Feed - High Cholesterol News and Research

IUPUI researchers receive NIH grant to study effect of depression treatment on cardiovascular disease

IUPUI researchers receive NIH grant to study effect of depression treatment on cardiovascular disease

Indiana University-Purdue University Indianapolis researchers led by Jesse Stewart of the School of Science, have received a $2.6 million grant from the National Institutes of Health to conduct the first randomized controlled trial to determine whether depression treatment can help prevent the development of cardiovascular disease. [More]
FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. [More]
EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia

EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the European Medicine Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion for the marketing authorization of Praluent (alirocumab), recommending its approval for use in certain adult patients with hypercholesterolemia. [More]
Nebraska researchers receive $3.5 million NIH grant to study stents for peripheral artery disease

Nebraska researchers receive $3.5 million NIH grant to study stents for peripheral artery disease

Researchers at the University of Nebraska Medical Center have received a five-year, $3.5 million grant funded by the National Institutes of Health to find out why stents don't work well for treating peripheral artery disease (PAD). [More]
Penn State Hershey cardiologist explains causes and symptoms of heart attack

Penn State Hershey cardiologist explains causes and symptoms of heart attack

It's possible to have a heart attack and not even know it. Maybe it's because you're stoic when it comes to pain and fatigue. Or maybe you write off your symptoms as heartburn or indigestion. It's even possible that your own body is kicking up its reserves to mask symptoms of what is happening inside. [More]
Phase 3 ODYSSEY JAPAN trial of Praluent injection meets primary endpoint

Phase 3 ODYSSEY JAPAN trial of Praluent injection meets primary endpoint

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint. [More]
UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

Sylvia Hernando became a Community Health Worker (CHW) because she wanted to help others. Hernando had been a stay-at-home mother and was looking to go back to school when she heard about the CHW certification program at The University of Texas Health Science Center at Houston School of Public Health. [More]
Experts call for healthy lifestyle initiatives to combat non-communicable diseases

Experts call for healthy lifestyle initiatives to combat non-communicable diseases

A group of the world's top doctors and scientists working in cardiology and preventive medicine have issued a call to action to tackle the global problem of deaths from non-communicable diseases (NCDs), such as heart problems, diabetes and cancer, through healthy lifestyle initiatives. [More]
Study: High blood pressure linked to lower risk for Alzheimer's disease

Study: High blood pressure linked to lower risk for Alzheimer's disease

A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer's disease. [More]
Johns Hopkins scientists use experimental therapy to reverse progression of atherosclerosis in rodents

Johns Hopkins scientists use experimental therapy to reverse progression of atherosclerosis in rodents

In what may be a major leap forward in the quest for new treatments of the most common form of cardiovascular disease, scientists at Johns Hopkins report they have found a way to halt and reverse the progression of atherosclerosis in rodents by loading microscopic nanoparticles with a chemical that restores the animals’ ability to properly handle cholesterol. [More]
Amgen to discuss data supporting Repatha BLA for high cholesterol treatment with FDA EMDAC

Amgen to discuss data supporting Repatha BLA for high cholesterol treatment with FDA EMDAC

Amgen today announced that the Company will discuss the data supporting the Repatha (evolocumab) Biologics License Application (BLA) for the treatment of high cholesterol with the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC). [More]
Study highlights the need to reduce non-communicable diseases

Study highlights the need to reduce non-communicable diseases

There is a great need to slow down the increasing number of people who die prematurely because of non-communicable diseases (NCDs) such as cardiovascular disease, diabetes and cancer. [More]
UC Davis researchers show feasibility of using statins to treat asthma

UC Davis researchers show feasibility of using statins to treat asthma

Statins continue to show that their benefits extend beyond their original focus of lowering high cholesterol. With the increasing prevalence of asthma, scientists are studying the effects of statins in the lungs. [More]
Researchers use American College of Cardiology registry to improve cardiovascular care delivery in India

Researchers use American College of Cardiology registry to improve cardiovascular care delivery in India

Despite challenges, it is feasible to collect and study the quality of outpatient cardiovascular care in a resource-limited environment like India, according to a pilot study published today in the Journal of the American Heart Association. [More]
Study explores non-biological factors that may cause fewer men to seek bariatric surgery

Study explores non-biological factors that may cause fewer men to seek bariatric surgery

A new study by researchers at the University of California, San Diego School of Medicine has identified demographic, socioeconomic and cultural factors that contribute to a major gender disparity among U.S. men and women undergoing weight loss surgeries. Men undergo the surgeries in far lower numbers than women. [More]
Chemists working to develop 'greener' processes for discovering, developing medicines

Chemists working to develop 'greener' processes for discovering, developing medicines

Chemists funded by NIH's National Institute of General Medical Sciences are working to develop "greener" processes for discovering, developing and manufacturing medicines and other molecules with therapeutic potential, as well as compounds used in biomedical research. [More]
UC San Diego study examines counterfeit drug penetration in global medicine supply chains

UC San Diego study examines counterfeit drug penetration in global medicine supply chains

When you take a medication for, say, high cholesterol, do you know that pill is really what the label says it is? Depending upon the type of medicine and where you live, the threat of falsified medications (also referred to as counterfeit, fraudulent, and substandard) can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researchers at University of California, San Diego School of Medicine in a new report published April 20 in the American Journal of Tropical Medicine and Hygiene. [More]
Majority of patients who survive cardiac arrest experience cognitive problems

Majority of patients who survive cardiac arrest experience cognitive problems

Half of all patients who survive a cardiac arrest experience problems with cognitive functions such as memory and attention. [More]
Genetic study may help identify novel targets for treatment of high blood pressure

Genetic study may help identify novel targets for treatment of high blood pressure

A genetic investigation of individuals in the Framingham Heart Study may prove useful to identify novel targets for the prevention or treatment of high blood pressure. The study, which takes a close look at networks of blood pressure-related genes, is published in the journal Molecular Systems Biology. [More]
Aspirin use continues to surge among older adults in US

Aspirin use continues to surge among older adults in US

A national survey suggests that slightly more than half of the older adults in the United States are now taking a daily dose of aspirin, even though its use is not recommended by the Food and Drug Administration for most people who have not yet had a heart attack or stroke. [More]
Advertisement
Advertisement